Health policy

Recent Scholarly Publications

Records 48 / 377

Evaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters

April 2015

BACKGROUND: Current guidelines for economic evaluations of health interventions define relevant outcomes as those accruing to individuals receiving interventions.

Global Impact of Antiretroviral Therapy-Associated Diarrhea

December 2012

The cost-effectiveness of preexposure prophylaxis for HIV prevention in men who have sex with men in the United States

December 2012

Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users

December 2012

Scientific evidence alone is not sufficient basis for health policy

December 2012

HIV Development Assistance and Adult Mortality in Africa

December 2012

Context  The effect of global health initiatives on population health is uncertain.

Characteristics of U.S. Emergency Departments That Offer Routine Human Immunodeficiency Virus Screening.

July 2012

The New Demographic Transition: Most Gains in Life Expectancy Now Realized Late in Life

June 2012

The share of increases in life expectancy realized after age 65 was only about 20 percent at the beginning of the 20th century for the United States and 16 other countries at comparable stages of...

Assessing Screening Policies for Childhood Obesity

January 2012

To address growing concerns over childhood obesity, the United States Preventive Services Task Force (USPSTF) recently recommended that children undergo obesity screening beginning at age 6.

Health Care for 1.3 Billion: An Overview of China’s Health System

January 2012

What kind of a health care system do China’s 1.3 billion turn to when ill, injured, or in need of care?

Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: A modeling analysis for ukraine

December 2011

Abstract BACKGROUND: Injection drug use (IDU) and heterosexual virus transmission both contribute to the growing mixed HIV epidemics in Eastern Europe and Central Asia.

Expected value information improves financial risk taking across the adult life span

December 2011

Abstract When making decisions, individuals must often compensate for cognitive limitations, particularly in the face of advanced age.

Inferring model parameters in network-based disease simulation

December 2011

Abstract Many models of infectious disease ignore the underlying contact structure through which the disease spreads.

Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions

December 2011

Abstract In an era of limited healthcare budgets, mathematical models can be useful tools to identify cost-effective programs and to support policymakers in informed decision making.

Assessing effectiveness and cost-effectiveness of concurrency reduction for HIV prevention

December 2011

Abstract We estimated the effectiveness and cost-effectiveness of changes in concurrent sexual partnerships in reducing the spread of HIV in sub-Saharan Africa.

Home blood pressure management and improved blood pressure control: results from a randomized controlled trial

December 2011

Abstract BACKGROUND: To determine which of 3 interventions was most effective in improving blood pressure (BP) control, we performed a 4-arm randomized trial with 18-month follow-up at the primary...

Improving practice guidelines with patient-specific recommendations

December 2011

Clinical practice guidelines aim to help providers make decisions that optimize patient care (1).

Determinants of the cost of health services used by veterans with HIV

December 2011

BACKGROUND: The effect of adherence, treatment failure, and comorbidities on the cost of HIV care is not well understood.

The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA

December 2011

OBJECTIVE: Acute HIV infection often causes influenza-like illness (ILI) and is associated with high infectivity.

The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: examining the RV144 trial results

December 2011

BACKGROUND: The prime-boost HIV vaccine regimen used in the recent RV144 trial resulted in modest efficacy of 31% over 3.5 years, but was substantially higher in the first year post-vaccination.

HIV-1 clade C envelopes obtained from late stage symptomatic Indian patients varied in their ability towards relative CD4 usages and sensitivity to CCR5 antagonist TAK-779

December 2011

The mechanism by which strictly CCR5 using HIV-1 clade C variants exacerbate disease progression in absence of coreceptor switch is not clearly known.

A single amino acid substitution in the C4 region in gp120 confers enhanced neutralization of HIV-1 by modulating CD4 binding sites and V3 loop

December 2011

Identification of vulnerability in the HIV-1 envelope (Env) will aid in Env-based vaccine design.

People

default people 100x120 Henry T. Greely Professor, Law
default people 100x120 Julie Parsonnet Professor, Medicine, Professor, Health Research and Policy
Zenios, Stefanos BW3x4 Stefanos A. Zenios Professor, Operations, Information and Technology, Professor, Health Care Management
profile picture cropped Mintu Turakhia Associate Professor, Medicine Affiliated Faculty
default people 100x120 Daniel P. Kessler Professor, Law, Professor, Political Economy
stafford Randall S. Stafford Professor, Medicine
Morton1 John Morton Associate Professor, Surgery
default people 100x120 Gina Li AHRQ Fellow, CHP/PCOR
viewimage Devika Bhushan Master Student, SHP
marissa reitsma profilephoto Marissa Reitsma PhD Student, CHP/PCOR
manuel garcia toca profilephoto Manuel Garcia Toca Master Student, SHP
kirbi Kirbi Yelorda AHRQ Fellow, CHP/PCOR